Biomarkers of metabolism, easily detectable with SD-OCT, indicate association with successful treatment of DME with DEX implant.
Collaborative clinical research by clinicians based in Tel Aviv University, Israel, University of Buenos Aires, Argentina, the University of Leipzig, Germany and the University of Milan, Italy have shown that certain SD-OCT biomarkers may act as useful image findings pointers in DEX treatment of diabetic macular edema (DME). The research, carried out on a total […]Read full story
Phased I/II clinical trial results for treatment of wet AMD with topical small molecule inhibitor of integrin αvβ3
A clinical trial study, entitled “Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)”, has reported topline results indicating safety and tolerability for a new topical formulation for the treatment of wet AMD. An eye-drop therapeutic capable of penetrating tissues at the back of the eye would represent […]Read full story
Patient organization fights to preserve pharmaceutical tax credits for development of orphan therapies in ophthalmology
Foundation Fighting Blindness USA (FFB), a US patient organisation advocating supports and research for individuals with retinal diseases, has openly criticized plans by the Trump administration to cut tax credits designed to encourage the development of treatments for rare disorders. The Orphan Tax Credit, a part of the US Orphan Drug Act 1983, provides tax […]Read full story